Trial Profile
A phase III study of Vx-001 in the treatment of patients with non-small cell lung cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Apr 2016
Price :
$35
*
At a glance
- Drugs Vx 001 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Apr 2016 New trial record